Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.320
+0.070 (3.11%)
At close: Mar 25, 2026, 4:00 PM EDT
2.320
0.00 (0.00%)
Pre-market: Mar 26, 2026, 7:02 AM EDT
Editas Medicine Employees
Editas Medicine had 87 employees as of December 31, 2025. The number of employees decreased by 159 or -64.63% compared to the previous year.
Employees
87
Change (1Y)
-159
Growth (1Y)
-64.63%
Revenue / Employee
$465,747
Profits / Employee
-$1,839,770
Market Cap
227.06M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 87 | -159 | -64.63% |
| Dec 31, 2024 | 246 | -19 | -7.17% |
| Dec 31, 2023 | 265 | 39 | 17.26% |
| Dec 31, 2022 | 226 | -38 | -14.39% |
| Dec 31, 2021 | 264 | 29 | 12.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Coherus Oncology | 147 |
| Voyager Therapeutics | 141 |
| C4 Therapeutics | 104 |
| Alector | 103 |
| Keros Therapeutics | 78 |
| Rezolute | 75 |
| Cybin | 50 |
| Camp4 Therapeutics | 48 |
EDIT News
- 13 days ago - Editas Medicine, Inc. (EDIT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 17 days ago - Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates - GlobeNewsWire
- 4 weeks ago - Editas Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Genflow Biosciences PLC Announces Directorate Change - Accesswire
- 4 months ago - Editas Medicine Announces Third Quarter 2025 Results and Business Updates - GlobeNewsWire
- 5 months ago - Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025 - GlobeNewsWire
- 5 months ago - Editas Medicine: Three Strikes And It's Out, Or Third Time's The Charm? - Seeking Alpha
- 5 months ago - Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress - GlobeNewsWire